Skip to content

Feasibility Study of Multidimensional Rehabilitation in the Metaverse

Feasibility Study of Multidimensional Rehabilitation in the Metaverse

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06354595
Enrollment
10
Registered
2024-04-09
Start date
2024-03-01
Completion date
2024-05-01
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Keywords

Metaverse multi-dimensional rehabilitation platform

Brief summary

The investigators evaluated and optimized the Metaverse multi-dimensional rehabilitation platform based on the use of the Metaverse multi-dimensional rehabilitation platform by colorectal cancer survivors and their families, and finally launched the Metaverse multi-dimensional rehabilitation platform.

Detailed description

The investigatorse intend to invite colorectal cancer survivors and their families to use the metaverse multi-dimensional rehabilitation platform. Interviews with users, user experience optimization of the metaverse multi-dimensional rehabilitation platform, and then evaluation of the platform through system usability evaluation. Gain insight into the experience of colorectal cancer survivors using the metaverse multi-dimensional rehabilitation platform, and understand their opinions and suggestions to explore the usability of the metaverse multi-dimensional rehabilitation platform.

Interventions

DEVICEMultidimensional Rehabilitation in the Metaverse

Using the multidimensional rehabilitation space in the metaverse, evaluate the platform after use.

Sponsors

The First Affiliated Hospital of Xiamen University
CollaboratorOTHER
Qu Shen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing adjuvant therapy after radical colorectal cancer resection; Age over 18 years old, under 65 years old, non-pregnant; Volunteering to participate in the research of this topic; Mobile phones are available

Exclusion criteria

* Patients with multiple cancers; Have special dietary needs.

Design outcomes

Primary

MeasureTime frameDescription
Post-Study System Usability Questionnaire (PSSUQ) Third Edition4th weekThe questionnaire includes three dimensions: usefulness, information quality, interface quality, and one overall evaluation item, totaling 20 items. Each item is rated on a scale from 'strongly disagree' to 'strongly agree' with scores ranging from 1 to 5. A higher score indicates higher user satisfaction.
System Usability Scale (SUS)4th weekUsed to evaluate user experience, employing the Likert 5-point scale method, consisting of 10 questions. Questions 1, 3, 5, 7, and 9 are positively worded, while questions 2, 4, 6, 8, and 10 are negatively worded. The validity of the scale is 0.85. The SUS is scored on a percentage scale. When the questionnaire score is above 70, the product is considered 'good,' and above 50 is considered 'okay.

Secondary

MeasureTime frameDescription
Semi-structured interview4th weekThrough interviews, conducting interviews with colorectal cancer patients on the theme of 'platform implementation effectiveness' to understand the evaluation of colorectal cancer patients on this mobile healthcare platform.

Countries

China

Contacts

Primary ContactQu SHEN
shenqumail@163.com+865922189613

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026